BioSpace4d
FDA Approval of Vertex’s Non-Opioid Journavx Signals New Era in Pain Treatment
If the attention generated by BioSpace’s coverage of this landmark approval is any indication, Americans are hungry for ...
European Medical Journal3d
Scalp Microbiome and Central Centrifugal Cicatricial Alopecia
Discover a recent study that has examined the scalp microbiome in Black women diagnosed with central centrifugal cicatricial ...
Yahoo Finance11d
Vertex Announces FDA Approval of JOURNAVX™ (suzetrigine), a First-in-Class Treatment for Adults With Moderate-to-Severe Acute Pain
"This is an incredible day for patients and physicians alike who now have an approved non-opioid treatment that delivers ... Pain Medicine in San Diego and Vertex Acute Pain Steering Committee ...
Vertex Pharmaceuticals stock is soaring. The FDA just approved its potentially game-changing pain treatment.
Shares of Vertex Pharmaceuticals Inc. surged ahead of Friday’s market open after the Food and Drug Administration approved ...
Yahoo Finance11d
FDA approves Vertex’s acute pain treatment Journavx
"FDA approves Vertex’s acute pain treatment Journavx" was originally created and published by Pharmaceutical Technology, a GlobalData owned brand. The information on this site has been included ...